Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 180

Results For "program"

1941 News Found

International Society of Pharmacovigilance opens South Asia chapter
Public Health | November 16, 2021

International Society of Pharmacovigilance opens South Asia chapter

The aim is to support Pharmacovigilance programme across the countries in the region


Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards
Policy | November 16, 2021

Indian Pharmacopoeia Commission revises and adds new impurities and IP reference standards

The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards


Research uncovers challenges for people with vascular disease
News | November 16, 2021

Research uncovers challenges for people with vascular disease

Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis


BGS Gleneagles Global hospital opens women’s cancer care centre
Hospitals | November 15, 2021

BGS Gleneagles Global hospital opens women’s cancer care centre

Early detection of breast cancer increases survival rate by 95 per cent


DawaDost rolls out diabetes medicine at Re 1 per day
Startup | November 13, 2021

DawaDost rolls out diabetes medicine at Re 1 per day

The start-up has announced the scheme to mark World Diabetes Day


Jubilant Biosys expands Chemistry Innovation Research Centre
Supply Chain | November 12, 2021

Jubilant Biosys expands Chemistry Innovation Research Centre

The centre has an initial capacity of 500 FTEs


Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
News | November 12, 2021

Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22

Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.


US govt places additional order of 1.4 million courses of molnupiravir
News | November 10, 2021

US govt places additional order of 1.4 million courses of molnupiravir

Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults


Pulmatrix resolves dispute with Cipla
News | November 10, 2021

Pulmatrix resolves dispute with Cipla

Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.


Intuitive India familiarises surgeons on Robotic-Assisted Surgery
Medical Device | November 10, 2021

Intuitive India familiarises surgeons on Robotic-Assisted Surgery

The workshop had been organized by the department of surgery at Jawaharlal Nehru Medical College (JNMC), Aligarh Muslim University (AMU), along with the Association of Surgeons of Aligarh (ASA)